Genetics company 23andme announced that they will be offering the first direct-to-consumer pharmacogenomics test starting this year. 23andMe has yet to say when the test will be available to patients and for how much This is the first authorization of a direct-to-consumer report on pharmacogenomics and came through the FDA’s de novo classification process. With this authorization, […]